Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • Mutual funds show consistent long-term performance amid short-term fluctuations: ICRA Analytics
    • Cigarette Maker Sampoerna Purchases Rp 500 Billion Patriot Bonds
    • Mutual fund SIP calculator: How much to invest per month to get Rs 1 crore in 20 years – Money News
    • Ethereum Price Fluctuates Before Inflation Report
    • 5 equity mutual funds delivered stellar 15%+ returns in a year – Money Insights News
    • Best Cryptos To Buy Today: BlockchainFX Presale Rockets As Ethereum And Solana Shift Gears
    • Best small-cap mutual funds 2025: 5 schemes beating benchmarks and compounding 30%+ returns – Money News
    • New Fidelis state bonds worth RON 2.2 bln to start trading on the Bucharest Stock Exchange
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Bonds»Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal
    Bonds

    Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal

    August 12, 2024


    Key Takeaways

    • Eli Lilly is selling bonds to fund the acquisition of drug developer Morphic. The sale is reportedly worth $5 billion.
    • The company’s stock was upgraded by Deutsche Bank analysts following its quarterly results last week.
    • Lilly shares jumped early in the day but closed in the red.

    Eli Lilly (LLY) shares finished Monday lower after a back-and-forth session in which an analyst upgrade sent them higher before news of $5 billion in bond sales pulled them into the red.

    Deutsche Bank analysts called the drugmaker a “high growth unicorn” and upgraded its shares to a buy rating. The bump was based in part on sales of the weight-loss drug Mounjaro, which more than tripled to $3.09 billion when the company reported earnings last week

    The firm upgraded its price target to $1,025 from $725, a nearly 15% premium to Lilly’s Friday closing price. Shares rose above $904 Monday morning. 

    Bonds Help Fund Morphic Acquisition

    The stock gave back its early gains after Bloomberg in a report said the company would sell $5 billion in bonds to help pay for its $3.2 billion acquisition of Morphic (MORF). Lilly in a regulatory filing confirmed the sale but offered fewer details.

    The deal, announced last month, adds Morphic’s flagship developmental drug for inflammatory bowel disease to Lilly’s portfolio. The company is also developing molecules intended to treat autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases, and cancer.

    Lilly will sell bonds in five chunks, including a 40-year note with a 1% higher yield than a U.S. Treasury note, according to the report. Corporate bonds are typically seen as riskier than U.S. government bonds, so they usually have higher interest rates to compensate.

    An Eli Lilly spokesperson declined to comment. Shares of the company closed Monday’s session down less than 1%,



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Cigarette Maker Sampoerna Purchases Rp 500 Billion Patriot Bonds

    October 23, 2025

    New Fidelis state bonds worth RON 2.2 bln to start trading on the Bucharest Stock Exchange

    October 23, 2025

    Banks could turn to cat bonds to hedge their climate risks: ADBI

    October 23, 2025
    Leave A Reply Cancel Reply

    Top Posts

    The Shifting Landscape of Art Investment and the Rise of Accessibility: The London Art Exchange

    September 11, 2023

    Charlie Cobham: The Art Broker Extraordinaire Maximizing Returns for High Net Worth Clients

    February 12, 2024

    Cigarette Maker Sampoerna Purchases Rp 500 Billion Patriot Bonds

    October 23, 2025

    The Unyielding Resilience of the Art Market: A Historical and Contemporary Perspective

    November 19, 2023
    Don't Miss
    Mutual Funds

    Mutual funds show consistent long-term performance amid short-term fluctuations: ICRA Analytics

    October 23, 2025

    ICRA Analytics reported that Indian mutual funds showed consistent long-term performance across both equity and…

    Cigarette Maker Sampoerna Purchases Rp 500 Billion Patriot Bonds

    October 23, 2025

    Mutual fund SIP calculator: How much to invest per month to get Rs 1 crore in 20 years – Money News

    October 23, 2025

    Ethereum Price Fluctuates Before Inflation Report

    October 23, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    Which Is the Better Buy?

    August 6, 2025

    Gatehouse Bank CEO talks about Shariah-compliant UK property investments for GCC buyers

    August 10, 2025

    Ford considers investing $400M for EV component production in Kentucky

    July 12, 2024
    Our Picks

    Mutual funds show consistent long-term performance amid short-term fluctuations: ICRA Analytics

    October 23, 2025

    Cigarette Maker Sampoerna Purchases Rp 500 Billion Patriot Bonds

    October 23, 2025

    Mutual fund SIP calculator: How much to invest per month to get Rs 1 crore in 20 years – Money News

    October 23, 2025
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    ₹10,000 monthly SIP in this mutual fund has grown to ₹1.52 crore in 22 years

    September 17, 2025
    © 2025 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.